




The STIMPOD NMS450X+ is the latest addition in our range of patient monitors. The NMS450X+ is your Quantitative Neuromuscular Blockade Monitor of choice.
It is the only handheld monitor that features both AMG and EMG functionality, offering you optimal patient care at the most affordable cost. Learn more
Do you have the older NMS450 or NMS450X model?
We have a special upgrade program for you.
Quantitative Neuromuscular Blockade monitor. The STIMPOD NMS450X features both AMG and EMG technology, offering you the ability to monitor 100% of your cases at the lowest cost.
Precision Nerve Locating device.
Features Nerve Mapping and Nerve Location.
* Stimulation needles not supplied
The EMG patient cable provides a secure connection to your EMG electrode and the STIMPOD. The EMG module hosts the EMG algorithm that provides validated and accurate EMG measurements. The module also provides a secure friction fit connection with a magnetic secured alignment to the EMG electrode connector.
Available in 1.8m and 3.5m
STIMPOD NMS450X+ (Software version 10.6 and higher)
STIMPOD NMS450X (Software version 10.3 and higher)
Device not compatible?
The AMG patient cable features a reusable accelerometer sensor that records data in a 3-dimensional space. This allows for easy setup and no calibration needed. The versatile sensor can acommodate monitoring of the ulnar nerve, posterior tibial nerve and facial nerves, making it the most cost-effective technology during open arm surgery setups.
Available in 1.8m and 3.5m
STIMPOD NMS450X+ (Software version 10.6 and higher)
STIMPOD NMS450X (Software version 9.8 and higher)
Device not compatible?
Auto sensing technology provides a solution for tanscutaneous nerve mapping and sub-cutaneous nerve location in a single cable. The current range is automatically adjusted based on the conduction path between the mapping pen and stimulation needle, ensuring quick and precise nerve location.
Available in 1.5m
2mm Needle connector
STIMPOD All versions
Experience unparalleled comfort and reliability with the patented ripple design EMG electrode. Specifically
engineered to fit both left and right hands, it effortlessly accommodates any hand size. Crafted from
soft, dermatoid material, it ensures maximum adhesion even during long surgeries with frequent patient
movements, guaranteeing uninterrupted NMBA monitoring.
Storage Temp: 3 – 27º Celcius
Operating Temp: 10 – 40º Celcius
STIMPOD NMS450X+ (Software version 10.6 and higher)
STIMPOD NMS450X (Software version 10.3 and higher)
The specially designed AMG electrode features a unique colour-coded cathode and anode in a single sticker. Versatile and adaptable, it can be applied to the hand, foot or face. The proprietary stimulation gel and gel interface significantly outperforms conventional Ag/AgCl ECG electrodes over long surgery times.
Storage Temp: 3 – 27º Celcius
Operating Temp: 10 – 40º Celcius
All
Display your NMT data live on a Philips Patient monitor.
RS232 interface
STIMPOD NMS450X
STIMPOD NMS450X+
Display your NMT data live on PC.
RS232 interface
USB interface
STIMPOD NMS450X
STIMPOD NMS450X+
Intergrate Objective NMT Monitoring to your patient monitor. The Xenith module provides all the functionality for 3-dimensional acceleromyography and electromyography.
Dimensions: 68mm x 56mm x 12mm
Supply Voltage: 4.5 – 6.5V
Weight: 50g
Customizable to any patient monitor
XT-47001 Xenith Development Kit
Secure your STIMPOD will a full range of 360 degree adjustments.
None.
STIMPOD NMS450
STIMPOD NMS450X
STIMPOD NMS450X+
Provides up to 40 hours of power to your STIMPOD.
21700 Li-ion battery
Capacity: 5000 mAh
STIMPOD NMS450X+
Conveniently charge your STIMPOD with a compatible
USB-A power adapter.
Firewire to USB-A
STIMPOD NMS450X+
Universal power adapter.
Input: 100 – 240 Vac, 50-60Hz
STIMPOD NMS450X+
Li-ion battery charger
Input Voltage: 5Vdc 1-2A
STIMPOD NMS450X+
|
The Stimpod NMS450X+, equipped with two different modalities (AMG and EMG), empowers anaesthesiologists to achieve safer intraoperative control of patients’ neuromuscular blockade. The full case NMT Monitoring enables safe extubation and eliminate residual paralysis in any hospital setting, provider preference and surgery type. This advanced technology empowers clinicians to have a safer and more precise control over the neuromuscular blockade during surgery, aligning with the latest guideline-concordant recommendations for the monitoring of patients for residual paralysis following the administration of a neuromuscular reversal agent. The ASA and ESAIC strongly recommend the use of a quantitative neuromuscular blocking agent monitor in conjunction with neuromuscular blocking agents.
While reversal drugs like Sugammadex are commonly used for NMBA reversal, they are not a foolproof solution and residual paralysis remains a significant concern based on clinical evidence. By incorporating the Stimpod NMS450X+ into their practice, anaesthesiologists can proactively monitor the depth of neuromuscular blockade, significantly reducing the incidence of residual paralysis in patients. This contributes to improved patient outcomes and a safer post-operative recovery.
The Stimpod NMS450X+ offers a cost-effective solution in the OR, PACU and ICU. With its two modalities, AMG and EMG, the device provides flexibility in monitoring options. The only neuromuscular monitoring system available with both AMG and EMG enabling cost control at the point-of-care based on need and specific setting, allowing affordable standardisation across the entire hospital. Cost of Care model, enabling monitoring of all drug usage to ensure optimal use, thus saving on both paralytic and recovery agents. This cost-saving feature ensures efficient resource management without compromising patient safety.
AMG offers the most cost-effective option to implement with a reusable sensor and versatile patient setup options enabling neuromuscular transmission monitoring of the hand, toe or face.
EMG is ideally suited for neuromuscular monitoring of surgeries where tucked hands and arms are required, with optimised performance through a patented, skin-like electrode.
Residual neuromuscular blockade after anaesthesia has been linked to severe complications and adverse outcomes, including increased oxygen desaturation, postoperative pneumonia, airway obstruction, and reintubation. By utilizing the Stimpod NMS450X+ and effectively preventing residual NMB, clinicians can contribute to reduced LOS in hospitals and improve patient recovery rates.
Anaesthesiologists worldwide who have adopted the Stimpod NMS450X+ demonstrate their commitment to following the latest guidelines and best practices in anaesthesia. By incorporating a quantitative NMBA monitor into their practice, clinicians align themselves with the recommendations set forth by the ASA and ESAIC, promoting a higher standard of care and patient safety. By utilizing the Stimpod NMS450X+, anaesthesiologists are a testament to its effectiveness to improve patients outcomes and can contribute to the reduction of adverse events and enhance the recovery process for their patients.